BrainStorm to Start Adult Stem Cell Trial for ALS

Israeli-based Brainstorm Cell Therapeutics received approval from the Israeli Ministry of Health to conduct a Phase I/II clinical trial of its adult stem cell therapy for individuals with ALS. The trial will include 12 individuals in the late stages of the disease and 12 individuals in the early stages.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail